{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"gastric-neuroendocrine-tumor-g1","columns":[{"gene":"","key":"population-0dcf8aa2a30a17f54a13","label":"gastric neuroendocrine tumor G1","mondoId":"MONDO:0006227","onsetQualifier":null,"originColumnKey":"MONDO:0006227/no-native-evidence","originalViews":[{"key":"MONDO:0006227/no-native-evidence","label":"gastric neuroendocrine tumor G1","scopeLabel":"No safely mapped HPO entry","sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"recordKeys":[],"recordQualifiers":{},"scopeLabel":"No safely mapped HPO entry","sourceIds":[],"sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-0dcf8aa2a30a17f54a13"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":["population-0dcf8aa2a30a17f54a13"],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"A well differentiated, low grade neuroendocrine tumor (carcinoid tumor) that arises from the stomach. The vast majority of cases arise from the corpus-fundus region. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. It may be associated with autoimmune chronic atrophic gastritis, multiple endocrine neoplasia type 1, or it may be sporadic.","mondoId":"MONDO:0006227","node":{"canonicalSlug":"gastric-neuroendocrine-tumor-g1","comparisons":[{"documentSha256":"ac034b8d569a1fbd8d9e7e80afac01b025c9b84359db84f8361d76256ef1012d","key":"expanded-digestive-system-neuroendocrine-neoplasm","kind":"expanded","label":"digestive system neuroendocrine neoplasm","memberIds":["MONDO:0000386","MONDO:0000540","MONDO:0002563","MONDO:0002882","MONDO:0002883","MONDO:0002993","MONDO:0002994","MONDO:0002995","MONDO:0003111","MONDO:0003504","MONDO:0003523","MONDO:0003524","MONDO:0003525","MONDO:0003621","MONDO:0003622","MONDO:0003646","MONDO:0003649","MONDO:0003708","MONDO:0003978","MONDO:0004116","MONDO:0004117","MONDO:0004210","MONDO:0004211","MONDO:0004236","MONDO:0004252","MONDO:0004333","MONDO:0004334","MONDO:0004377","MONDO:0004411","MONDO:0005048","MONDO:0005815","MONDO:0005893","MONDO:0006091","MONDO:0006093","MONDO:0006126","MONDO:0006155","MONDO:0006162","MONDO:0006219","MONDO:0006227","MONDO:0006229","MONDO:0006250","MONDO:0006257","MONDO:0006347","MONDO:0006348","MONDO:0006405","MONDO:0006976","MONDO:0015062","MONDO:0015063","MONDO:0015064","MONDO:0015065","MONDO:0015066","MONDO:0015067","MONDO:0015068","MONDO:0015069","MONDO:0015072","MONDO:0015073","MONDO:0018016","MONDO:0018017","MONDO:0018510","MONDO:0018698","MONDO:0018742","MONDO:0019954","MONDO:0019955","MONDO:0019957","MONDO:0019959","MONDO:0019960","MONDO:0021101","MONDO:0021533","MONDO:0021534","MONDO:0021535","MONDO:0023206","MONDO:0024500","MONDO:0024501","MONDO:0024502","MONDO:0024503","MONDO:0024504","MONDO:0024638","MONDO:0024639","MONDO:0024642","MONDO:0024677"],"mondoId":"MONDO:0024503","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-ac034b8d569a1fbd8d9e.ac034b8d569a1fbd8d9e7e80afac01b025c9b84359db84f8361d76256ef1012d.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"gastric neuroendocrine tumor G1","paragraphs":["A well differentiated, low grade neuroendocrine tumor (carcinoid tumor) that arises from the stomach. The vast majority of cases arise from the corpus-fundus region. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. It may be associated with autoimmune chronic atrophic gastritis, multiple endocrine neoplasia type 1, or it may be sporadic."],"scope":"exact","source":"MONDO","upstream":"NCIT:P378","url":"https://monarchinitiative.org/MONDO:0006227"},"ownColumnKeys":["population-0dcf8aa2a30a17f54a13"],"publication":"published","relationships":[{"kind":"parent","label":"carcinoid tumor","mondoId":"MONDO:0005369","slug":"carcinoid-tumor"},{"kind":"parent","label":"gastric neuroendocrine tumor, well differentiated, low or intermediate grade","mondoId":"MONDO:0015062","slug":"gastric-neuroendocrine-tumor-well-differentiated-low-or-intermediate-grade"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/24341"}],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0006227\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>NCIT:P378</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A well differentiated, low grade neuroendocrine tumor (carcinoid tumor) that arises from the stomach. The vast majority of cases arise from the corpus-fundus region. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. It may be associated with autoimmune chronic atrophic gastritis, multiple endocrine neoplasia type 1, or it may be sporadic.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0006227\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"gastric-neuroendocrine-tumor-g1","sourceDocuments":[{"name":"MONDO: gastric neuroendocrine tumor G1","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0006227"}],"sourceNote":"","synonyms":["gastric carcinoid tumor","gastric carcinoid tumour","gastric ECL cell NET","gastric ECL cell NET G1","gastric ECL cell, histamine-producing NET","gastric ECL-cell carcinoid tumor","gastric ECL-cell carcinoid tumour","gastric enterochromaffin-like cell carcinoid tumor","gastric enterochromaffin-like cell carcinoid tumour","gastric enterochromaffin-like cell neuroendocrine tumor","gastric enterochromaffin-like cell neuroendocrine tumour","gastric NET G1","grade 1 neuroendocrine neoplasm of stomach","stomach carcinoid tumor","stomach carcinoid tumour","stomach NET G1","stomach neuroendocrine neoplasm G1","stomach neuroendocrine tumor, well differentiated, low grade"],"takeawayHtml":"","title":"gastric neuroendocrine tumor G1"},"schemaVersion":1}
